Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.635 EUR | -0.91% | -2.10% | -2.45% |
May. 30 | Illimity on top; Exprivia on bottom | AN |
May. 23 | Exprivia on top; down Bioera | AN |
Sales 2022 | 178M 193M | Sales 2023 | 197M 214M | Capitalization | 78.27M 84.88M |
---|---|---|---|---|---|
Net income 2022 | 11M 11.93M | Net income 2023 | 13M 14.1M | EV / Sales 2022 | 0.49 x |
Net Debt 2022 | 23.64M 25.64M | Net Debt 2023 | 13.82M 14.98M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
6
x | P/E ratio 2023 |
6.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 13.38% |
1 day | -0.91% | ||
1 week | -2.10% | ||
1 month | -2.39% | ||
3 months | -0.91% | ||
6 months | -1.62% | ||
Current year | -2.45% |
Managers | Title | Age | Since |
---|---|---|---|
Domenico Favuzzi
CEO | Chief Executive Officer | 62 | 05-06-28 |
Donato Dalbis
DFI | Director of Finance/CFO | 51 | 16-12-31 |
Dante Altomare
BRD | Director/Board Member | 69 | 05-06-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Domenico Favuzzi
CEO | Chief Executive Officer | 62 | 05-06-28 |
Dante Altomare
BRD | Director/Board Member | 69 | 05-06-28 |
Director/Board Member | 81 | 20-12-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.635 | -0.91% | 7,598 |
24-05-30 | 1.65 | -4.07% | 8,855 |
24-05-29 | 1.72 | +2.38% | 1,499 |
24-05-28 | 1.68 | +0.30% | 76,451 |
24-05-27 | 1.675 | +0.30% | 71,650 |
Real-time Borsa Italiana, May 31, 2024 at 11:44 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.45% | 80.99M | |
+11.15% | 322B | |
+18.98% | 209B | |
-7.01% | 135B | |
+15.40% | 58.88B | |
+10.82% | 31.88B | |
+5.26% | 31.14B | |
+141.36% | 27.04B | |
+28.26% | 21.23B | |
+4.40% | 13.56B |
- Stock Market
- Equities
- XPR Stock